Multiplex PCR and Next Generation Sequencing for the Non-Invasive Detection of Bladder Cancer

Carbonic Anhydrase IX as a Diagnostic Urinary Marker for Urothelial Bladder Cancer

(2015) Michela de Martino et al.   EUROPEAN UROLOGY

Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus

(2015) Bernd J. Schmitz-Dräger et al.   UROLOGIA INTERNATIONALIS

Comprehensive molecular characterization of urothelial bladder carcinoma

(2014)   NATURE

TERT Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine

(2013) I. Kinde et al.   CANCER RESEARCH

Highly prevalentTERTpromoter mutations in bladder cancer and glioblastoma

(2013) Xiaoli Liu et al.   CELL CYCLE

A 3-Plex Methylation Assay Combined with the FGFR3 Mutation Assay Sensitively Detects Recurrent Bladder Cancer in Voided Urine

(2013) R. Kandimalla et al.   CLINICAL CANCER RESEARCH

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013

(2013) Marko Babjuk et al.   EUROPEAN UROLOGY

Comprehensive Mutation Analysis of the TERT Promoter in Bladder Cancer and Detection of Mutations in Voided Urine

(2013) Carolyn D. Hurst et al.   EUROPEAN UROLOGY

TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism

(2013) P. S. Rachakonda et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

(2013) P. J. Killela et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Narrow band imaging diagnosis of bladder cancer: systematic review and meta-analysis

(2012) Changjian Zheng et al.   BJU INTERNATIONAL

Diagnosis of Bladder Cancer Recurrence Based on Urinary Levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 Hypermethylation

(2012) Thomas Reinert et al.   PLoS One

Diagnosis, evaluation and treatment of carcinoma in situ of the urinary bladder: The state of the art

(2010) Sean R. Williamson et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

The West Midlands Bladder Cancer Prognosis Programme: rationale and design

(2009) Maurice P. Zeegers et al.   BJU INTERNATIONAL